These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2936315)

  • 1. Neurochemistry of dopamine in Huntington's dementia and normal aging.
    Stahl SM; Thiemann S; Faull KF; Barchas JD; Berger PA
    Arch Gen Psychiatry; 1986 Feb; 43(2):161-4. PubMed ID: 2936315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homovanilic acid in Huntington's disease and Sydenham's chorea.
    Cunha L; Oliveira CR; Diniz M; Amaral R; Conçalves AF; Pio-Abreu J
    J Neurol Neurosurg Psychiatry; 1981 Mar; 44(3):258-61. PubMed ID: 6453208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF homovanillic acid: an index of dopaminergic activity.
    Curzon G
    Adv Neurol; 1975; 9():349-57. PubMed ID: 125031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (HIAA) in the CSF after administration of probenecid in Huntington's chorea. Effect of lithium carbonate].
    Livrea P; Di Reda L; Ragno G; Germinario L; Papagno G
    Riv Neurobiol; 1977; 23(3):149-59. PubMed ID: 154166
    [No Abstract]   [Full Text] [Related]  

  • 5. Cerebrospinal fluid homovanillic acid is reduced in untreated Huntington's disease.
    García Ruiz PJ; Mena MA; Sanchez Bernardos V; Díaz Neira W; Gimenez Roldan S; Benitez J; García de Yebenes J
    Clin Neuropharmacol; 1995 Feb; 18(1):58-63. PubMed ID: 8665535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid homovanillic acid and parkinsonism in Huntington's disease.
    Kurlan R; Goldblatt D; Zaczek R; Jeffries K; Irvine C; Coyle J; Shoulson I
    Ann Neurol; 1988 Aug; 24(2):282-4. PubMed ID: 2972251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical aspects of Huntington's chorea.
    Caraceni T; Calderini G; Consolazione A; Riva E; Algeri S; Girotti F; Spreafico R; Branciforti A; Dall'olio A; Morselli PL
    J Neurol Neurosurg Psychiatry; 1977 Jun; 40(6):581-7. PubMed ID: 143508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased cerebrospinal fluid dopamine and 3,4-dihydroxyphenylacetic acid levels in Huntington's disease: evidence for an overactive dopaminergic brain transmission.
    Garrett MC; Soares-da-Silva P
    J Neurochem; 1992 Jan; 58(1):101-6. PubMed ID: 1309230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF monamine metabolites in movement disorders and normal aging.
    Stahl SM; Faull KF; Barchas JD; Berger PA
    Arch Neurol; 1985 Feb; 42(2):166-9. PubMed ID: 2579626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 14C-homovanillic acid in the cerebrospinal fluid of parkinsonian patients after intravenous 14C-L-dopa.
    Extein I; Van Woert M; Roth RH; Bowers MB
    Biol Psychiatry; 1976 Apr; 11(2):227-32. PubMed ID: 971447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apomorphine, pimozide, L-Dopa and the probenecid test in Huntington's chorea.
    Lal S; De la Vega C; Garelis E; Sourkes TL
    Psychiatr Neurol Neurochir; 1973; 76(2):113-7. PubMed ID: 4267059
    [No Abstract]   [Full Text] [Related]  

  • 12. Biogenic amine disturbances in cerebrospinal fluid in parkinsonism and unipolar depression: use of the probenecid method.
    Vanderheyden JE; Noel G; Mendlewicz J
    Neuropsychobiology; 1981; 7(3):137-51. PubMed ID: 6164951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced brain delivery of homovanillic acid to cerebrospinal fluid during human aging.
    Rapoport SI; Schapiro MB; May C
    Arch Neurol; 2004 Nov; 61(11):1721-4. PubMed ID: 15534183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Central metabolism of dopamine and serotonin. II. Significance of cerebrospinal fluid HVA and 5-HIAA changes in extrapyramidal and cerebellar syndromes].
    Buscaino GA; Mandarini A; Campanella G; Carrieri P; Orefice G
    Acta Neurol (Napoli); 1976; 31(5):565-70. PubMed ID: 138340
    [No Abstract]   [Full Text] [Related]  

  • 15. Elevated serotonin and reduced dopamine in subregionally divided Huntington's disease striatum.
    Kish SJ; Shannak K; Hornykiewicz O
    Ann Neurol; 1987 Sep; 22(3):386-9. PubMed ID: 2445259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Approaches to the study of dopamine metabolism in various extrapyramidal diseases].
    Barkhatova VP; Kandel' EI; Demina EG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(7):1021-9. PubMed ID: 6457476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of gamma-aminobutyric acid in human brain may increase dopaminergic neuronal function.
    Perry TL; Ito M; Jones K; Hansen S
    Neurosci Lett; 1984 Sep; 50(1-3):67-71. PubMed ID: 6238245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amine metabolites in the cerbrospinal fluid in Huntington's chorea.
    Curzon G; Gumpert J; Sharpe D
    J Neurol Neurosurg Psychiatry; 1972 Aug; 35(4):514-9. PubMed ID: 4261957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma homovanillic acid and prolactin in Huntington's disease.
    Markianos M; Panas M; Kalfakis N; Vassilopoulos D
    Neurochem Res; 2009 May; 34(5):917-22. PubMed ID: 18841471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic, multiple tics of Gilles de la Tourette's disease. CSF acid monoamine metabolites after probenecid administration.
    Cohen DJ; Shaywitz BA; Caparulo B; Young JG; Bowers MB
    Arch Gen Psychiatry; 1978 Feb; 35(2):245-50. PubMed ID: 272137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.